granzyme F Inhibitors

Chemical inhibitors of granzyme F can function through a variety of mechanisms, each related to the protein's role in cellular apoptosis and protease networks. Ac-IETD-CHO operates by targeting caspase-8, an enzyme essential for the activation of apoptosis through the granzyme B pathway, to which granzyme F is structurally related. By inhibiting caspase-8, Ac-IETD-CHO can prevent the downstream effects that might include granzyme F activity. Similarly, Z-FA-FMK, as a pan-caspase inhibitor, blocks the broad spectrum of caspase activity, thereby indirectly preventing any potential amplification of granzyme F's role in these pathways. Gabexate mesilate and Nafamostat mesilate both serve as serine protease inhibitors, directly targeting the serine protease activity of granzyme F, which is crucial for its function in inducing programmed cell death.

In the same vein, Sivelestat and AEBSF also inhibit granzyme F by aiming at the serine protease activity. Sivelestat, while selective for neutrophil elastase, can inhibit granzyme F due to the structural similarities in serine proteases. AEBSF irreversibly modifies the active site serine residue of granzyme F, rendering it inactive. Aprotinin contributes to this inhibitory profile by forming stable complexes with serine proteases like granzyme F, therefore obstructing the active sites essential for their proteolytic action. Moreover, Loxistatin and E-64, which are potent inhibitors of cysteine proteases, can indirectly affect the protease network within cells, thereby potentially destabilizing the activity or the presence of granzyme F. Belnacasan prevents the activation of inflammatory caspases that may be involved in the same pathways as granzyme F, thus indirectly affecting its function. Marimastat, by inhibiting matrix metalloproteases, can alter the extracellular matrix remodeling, which in turn, may affect the cellular responses that granzyme F is part of. Lastly, Crizotinib, known as a tyrosine kinase inhibitor, can alter signaling pathways within immune cells, which may influence the release or activation of granzyme F-containing cytotoxic granules.